Reports of Patent, Design, and Trade Mark Cases, Issues 13-25Published at the Patent Office Sales Branch, 2007 - Industrial property |
From inside the book
Results 1-3 of 70
Page 663
... period , E is incapable ( so long as his own mark remains unregistered ) of doing anything to prevent the 5 year period building up . Far from being a period of toleration , it is a period of frustration for E. He has to hope that the ...
... period , E is incapable ( so long as his own mark remains unregistered ) of doing anything to prevent the 5 year period building up . Far from being a period of toleration , it is a period of frustration for E. He has to hope that the ...
Page 830
... period specified by s.46 ( 1 ) ( a ) of the Act began on the day after the date on which the registration process was completed which in this case was February 10 , 2001 , and so the period would run until February 9 , 2006 , and ...
... period specified by s.46 ( 1 ) ( a ) of the Act began on the day after the date on which the registration process was completed which in this case was February 10 , 2001 , and so the period would run until February 9 , 2006 , and ...
Page 844
... period occurs in time but tells one nothing specific about where it starts . How does one calculate the date , the relevant five - year period he asked rhetorically ? He took me to Art . 12 of the Directive and in particular the ...
... period occurs in time but tells one nothing specific about where it starts . How does one calculate the date , the relevant five - year period he asked rhetorically ? He took me to Art . 12 of the Directive and in particular the ...
Contents
EDITORS INTRODUCTION | v |
CASES REPORTED IN NUMERICAL ORDER | xiv |
CASES NOTED IN JUDGMENTS AND DECISIONS REPORTED | xxiv |
Copyright | |
1 other sections not shown
Other editions - View all
Common terms and phrases
added subject matter agreement Akzo Nobel Angiotech Pharmaceuticals Inc Appeal to Court application for revocation Appointed Person BACTIGUARD chiral citalopram claimants co-proprietor's application common general knowledge comparative advertising Comptroller consent Court of Appeal decision declarations of invalidity DESIGN AND TRADE divisional applications Dr Pinkava duties earlier mark earlier trade mark enantiomers European patents evidence grounds for refusal Halliburton Energy Services hearing officer Intellectual Property Office inventive step issue jurisdiction L'Oréal licence LIFFE likelihood of confusion Lundbeck Malynicz non-use opposition parallel trading particulars of infringement patentable subject matter Patents Act 1977 Patents Court perfumes pharmaceutical Playtech prior art racemate referred registered proprietor registered trade mark registrar relation relative grounds relevant REPORTS OF PATENT restenosis skilled person smell-alike specification stent Sweet & Maxwell taxol tibolone TRADE MARK 2007 Trade Mark Application trade marks declarations United Kingdom validating amendments VITALITE Vitasoy